Trial Details
COMPLETEDBasic Information
| Clinical ID | c2447 |
|---|---|
| Identifier | NCT03471728 |
| Trial Title | Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)|Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: linaclotide |
Participant Information
| Sponsor | Astellas Pharma Inc |
|---|---|
| City | Aichi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2017-10-02 |
|---|---|
| Primary Completion Date | 2021-12-31 |
| Completion Date | 2021-12-31 |